NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/22/2025
Back to search
Official data from USPTO
SOCTEC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SOCTEC
ST13
US500000086364754Class
5, 10, 42, 44
Filing
86364754
Registration
5494819
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
02/11/2025
Trademark type
Word
Nice classes
5, 10, 42, 44
Filing date
08/12/2014
Registration date
06/19/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/22/2025
Last transaction
02/11/2025
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
SAINT-QUENTIN-FALLAVIER, FR
Examiner
HENRY,NAKIA D
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SKYEPHARMA PRODUCTION S.A.S.
Jagotec AG
Representatives
Molly Buck Richard RICHARD LAW GROUP
Technical classification
Nice Classes
Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals having a self-orienting effectorally delivered pharmaceuticals with modified time release into the gastrointestinal system; gastro retentive pharmaceuticals; self orienting pharmaceuticals in the form of capsulescapsules consisting of segments of varied functions and absorption ratesresulting in controlled release into the gastrointestinal tract; Gastrointestinal drug delivery preparations for medicalsurgical and biological purposes; chronotherapy-focused tabletsanalgesics; Medicines for treatment or prevention of cancerinfectious diseasefungal diseasesdiseases caused by parasiteshookwormspinwormsroundwormstapewormsflukesgiardiaentameobacryptosporidiumtoxoplasmosissleeping sicknesstrichuriasisisosporiasismalariaparasitic skin disease and leishmaniasiseye diseasesdiseases of the central and peripheral nervous systemsataxiadementiaepilepsyAlzheimer'scerebral palsystrokemotor neuron diseaseParkinson's diseasespinal injuryavulsion injury and peripheral neuropathiescardiovascular diseasediseases affecting the immune systemcancerCrohn's diseaseAIDSHIVlupusceliac diseasediabetesGrave's diseaseGuillain-Barré syndromeAddison's diseaseHashimoto's diseasemyasthenia gravisnarcolepsypernicious anaemiarheumatoid arthritispsoriasisulcerative colitisimmunodeficiency and inflammatory diseasesinherited diseasesgenetic disordershemophiliacystic fibrosis and Huntingdon'ssingle gene disordersbone and blood diseases and reproductive system disorders; medicinal preparations for treatment or prevention of cancerinfectious diseasefungal diseasesdiseases caused by parasiteshookwormspinwormsroundwormstapewormsflukesgiardiaentameobacryptosporidiumtoxoplasmosissleeping sicknesstrichuriasisisosporiasismalariaparasitic skin disease and leishmaniasiseye diseasesdiseases of the central and peripheral nervous systemsataxiadementiaepilepsyAlzheimer'scerebral palsystrokemotor neuron diseaseParkinson's diseasespinal injuryavulsion injury and peripheral neuropathiescardiovascular diseasediseases affecting the immune systemcancerCrohn's diseaseAIDSHIVlupusceliac diseasediabetesGrave's diseaseGuillain-Barré syndromeAddison's diseaseHashimoto's diseasemyasthenia gravisnarcolepsypernicious anaemiarheumatoid arthritispsoriasisulcerative colitisimmunodeficiency and inflammatory diseasesinherited diseasesgenetic disordershemophiliacystic fibrosis and Huntingdon'ssingle gene disordersbone and blood diseases and reproductive system disorders; capsules for the release of colonic drug delivery; pharmaceuticals for the treatment or prevention of cancerinfectious diseasefungal diseasesdiseases caused by parasiteshookwormspinwormsroundwormstapewormsflukesgiardiaentameobacryptosporidiumtoxoplasmosissleeping sicknesstrichuriasisisosporiasismalariaparasitic skin disease and leishmaniasiseye diseasesdiseases of the central and peripheral nervous systemsataxiadementiaepilepsyAlzheimer'scerebral palsystrokemotor neuron diseaseParkinson's diseasespinal injuryavulsion injury and peripheral neuropathiescardiovascular diseasediseases affecting the immune systemcancerCrohn's diseaseAIDSHIVlupusceliac diseasediabetesGrave's diseaseGuillain-Barré syndromeAddison's diseaseHashimoto's diseasemyasthenia gravisnarcolepsypernicious anaemiarheumatoid arthritispsoriasisulcerative colitisimmunodeficiency and inflammatory diseasesinherited diseasesgenetic disordershemophiliacystic fibrosis and Huntingdon'ssingle gene disordersbone and blood diseases and reproductive system disordersmedical and veterinary preparations for body slimming purposes; capsulessuppositoriestablets and pills for pharmaceuticalmedical and veterinary purposes for the treatment or prevention of cancerinfectious diseasefungal diseasesdiseases caused by parasiteshookwormspinwormsroundwormstapewormsflukesgiardiaentameobacryptosporidiumtoxoplasmosissleeping sicknesstrichuriasisisosporiasismalariaparasitic skin disease and leishmaniasiseye diseasesdiseases of the central and peripheral nervous systemsataxiadementiaepilepsyAlzheimer'scerebral palsystrokemotor neuron diseaseParkinson's diseasespinal injuryavulsion injury and peripheral neuropathiescardiovascular diseasediseases affecting the immune systemcancerCrohn's diseaseAIDSHIVlupusceliac diseasediabetesGrave's diseaseGuillain-Barré syndromeAddison's diseaseHashimoto's diseasemyasthenia gravisnarcolepsypernicious anaemiarheumatoid arthritispsoriasisulcerative colitisimmunodeficiency and inflammatory diseasesinherited diseasesgenetic disordershemophiliacystic fibrosis and Huntingdon'ssingle gene disordersbone and blood diseases and reproductive system disorders; pre-filled vials containing medical diagnostic reagents; exclude goods being related to the treatment of respiratory diseases
Class 10
inhalers for medical purposes; injection apparatusinstruments and devicesmedical apparatus in the nature of an infusion injection device for administering drugs; apparatusinstruments and devicesautomated drug delivery systems for storing and dispensing medicalsurgical and veterinary preparationscapsulespowderstablets and pills; instruments and apparatus for the administration of self-orientation therapy and prophylaxis preparations and substancesgastrointestinal drug delivery systemssyringes and fluid injectors for medical purposes; exclude goods being related to the treatment of respiratory diseases
Class 42
Scientific and technological servicescustom design exclusively in the pharmaceuticals and medical fields; design services exclusively in the pharmaceuticals and medical fields; drug development and custom design of pharmaceuticals and medical goods; exclude services in the field of inhalation technology
Class 44
Medical services; veterinary services; hygienic care for human beings or animals; medical analysis for the diagnosis and treatment of persons treatment or prevention of cancerinfectious diseasefungal diseasesdiseases caused by parasiteshookwormspinwormsroundwormstapewormsflukesgiardiaentameobacryptosporidiumtoxoplasmosissleeping sicknesstrichuriasisisosporiasismalariaparasitic skin disease and leishmaniasiseye diseasesdiseases of the central and peripheral nervous systemsataxiadementiaepilepsyAlzheimer'scerebral palsystrokemotor neuron diseaseParkinson's diseasespinal injuryavulsion injury and peripheral neuropathiescardiovascular diseasediseases affecting the immune systemcancerCrohn's diseaseAIDSHIVlupusceliac diseasediabetesGrave's diseaseGuillain-Barré syndromeAddison's diseaseHashimoto's diseasemyasthenia gravisnarcolepsypernicious anaemiarheumatoid arthritispsoriasisulcerative colitisimmunodeficiency and inflammatory diseasesinherited diseasesgenetic disordershemophiliacystic fibrosis and Huntingdon'ssingle gene disordersbone and blood diseases and reproductive system disorders; pharmacy advice; provision of information relating to medicalsurgical and veterinary matters online from a computer database or over the Internet; exclude services in the field of inhalation technology
Publications
History of USPTO decisions and trademark events.
63 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/22/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/21/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/29/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/19/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/19/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/29/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/03/2018
PUBO
PUBLISHED FOR OPPOSITION
04/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/14/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/26/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
02/13/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/12/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
02/12/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/12/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/27/2017
GNRT
NON-FINAL ACTION E-MAILED
11/27/2017
CNRT
NON-FINAL ACTION WRITTEN
11/27/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/03/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/03/2017
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/02/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
10/31/2017
GNSL
LETTER OF SUSPENSION E-MAILED
10/31/2017
CNSL
SUSPENSION LETTER WRITTEN
10/31/2017
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/31/2017
OTHE
CASE RETURNED TO EXAMINATION
10/31/2017
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/31/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/09/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2017
PUBO
PUBLISHED FOR OPPOSITION
03/14/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/07/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/31/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
08/15/2016
GPRA
PRIORITY ACTION E-MAILED
08/15/2016
CPRA
PRIORITY ACTION WRITTEN
08/15/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
07/20/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/14/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/14/2016
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/14/2016
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/20/2016
GNSL
LETTER OF SUSPENSION E-MAILED
01/20/2016
CNSL
SUSPENSION LETTER WRITTEN
01/20/2016
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/29/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/25/2015
GNSL
LETTER OF SUSPENSION E-MAILED
06/25/2015
CNSL
SUSPENSION LETTER WRITTEN
06/25/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2015
ALIE
ASSIGNED TO LIE
06/01/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/26/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/26/2014
GNRT
NON-FINAL ACTION E-MAILED
11/26/2014
CNRT
NON-FINAL ACTION WRITTEN
11/26/2014
DOCK
ASSIGNED TO EXAMINER
11/25/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2014
NWAP
NEW APPLICATION ENTERED
08/15/2014
Continuous trademark protection
Get notified about every new filing that threatens SOCTEC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.